Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02900261
Other study ID # 2016-01178
Secondary ID
Status Completed
Phase
First received September 9, 2016
Last updated April 18, 2018
Start date September 28, 2016
Est. completion date February 18, 2018

Study information

Verified date April 2018
Source University of Lausanne Hospitals
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will compare different methods (24 hour urine collection, evening and morning spots, and questionnaires) to measure the consumption of sodium and cafeine in children and adolescents.


Description:

Sodium consumption among adults is high in Switzerland, as in most parts of the world. It is expected to be high in children as well, but little is still known. 24 hour urine collection is the golden standard to assess sodium consumption. However, this method is logistically difficult, especially for children. Therefore, alternatives are needed. Urinary spots have been used as a proxy to estimate sodium excretion over 24 hour in adults, but not in children. This study will assess whether urinary spots can be used to estimate sodium consumption in children in comparison to 24 hour urine collections.

Caffeine consumption has risen in children over the past years, mainly before of the increase in consumption of soda drinks. A precise way to measure caffeine consumption is by assessing the concentration of caffeine and its metabolites in 24 hour urine samples. An alternative to 24 hour urine collection is using questionnaires, however this remains difficult due to the multiples food sources of caffeine. This study will compare caffeine consumption estimated by 24 hour urine collection and by a semi-quantitative food frequency questionnaire targeting caffeine containing products.


Recruitment information / eligibility

Status Completed
Enrollment 101
Est. completion date February 18, 2018
Est. primary completion date February 18, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years to 16 Years
Eligibility Inclusion Criteria:

- Between 6 and 16 years of age

Exclusion Criteria:

- A sickness that affects the consumption and excretion of sodium and caffeine (for example, diabetes, cardiovascular or gastrointestinal problems, chronic kidney disease, renal insufficiency)

- Taking medication that affects sodium excretion (for example, diuretics)

- A intravenous perfusion during the urine collection

- Insufficient knowledge of French to understand the instructions

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention
This study is observational and does not entail any intervention. Different methods to assess sodium and caffeine consumption will be compared.

Locations

Country Name City State
Switzerland Hôpital du Valais Sion Valais

Sponsors (3)

Lead Sponsor Collaborator
University of Lausanne Hospitals Federal Food Safety and Veterinary Office, Hôpital du Valais

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Urinary sodium excretion Measured in 24 hour urine and estimated from 3 different urinary spots Over a 2-day period
Primary Urinary caffeine and related metabolites excretion Measured in 24 hour urine and estimated by a semi-quantitative food frequency questionnaire Over a 2-day period
Secondary Sodium consumption Estimated by a semi-quantitative food frequency questionnaire Over a 2-day period
Secondary Urinary phosphate excretion Measured in 24 hour urine and estimated from 3 different urinary spots Over a 2-day period
Secondary Urinary caffeine and metabolites excretion Measured in 24 hour urine and estimated from 3 different urinary spots Over a 2-day period
Secondary Urinary albumine excretion Measured in 24 hour urine and estimated from 3 different urinary spots Over a 2-day period
Secondary Urinary protein excretion Measured in 24 hour urine and estimated from 3 different urinary spots Over a 2-day period
See also
  Status Clinical Trial Phase
Completed NCT06038903 - The Turkish Version Of The Brief-Caffeine Expectancy Questionnaire
Completed NCT03850275 - The Effects of e+Shots Energy Beverage on Mental Energy N/A
Completed NCT01924481 - Effects of a Cocoa Shot on the Human Brain N/A
Completed NCT01330680 - Genetic Determinants of Cardiovascular Response to Coffee Drinking N/A
Completed NCT00184912 - The Effect of Caffeine on Ischemic Preconditioning N/A
Completed NCT03859882 - Protocol PERCAF 2018 N/A
Completed NCT02832401 - The Impact of Caffeine on Cognition in Schizophrenia N/A
Completed NCT04560595 - Remote Guided Caffeine Reduction N/A
Recruiting NCT05503732 - Effects of Energy Drinks on Sleep and Cardiovascular Health N/A
Not yet recruiting NCT05521386 - The Effects of Caffeine on Heart Rate and Heart Rate Variability N/A
Completed NCT06039358 - Effects of Caffeine Ingestion on the Biomechanics of Healthy Young Subjects N/A
Active, not recruiting NCT04547868 - Can Coffee/Caffeine Improve Post-Operative Gastrointestinal Recovery N/A
Completed NCT05559372 - Energy Drink Effects on Performance, Mood, and Cardiovascular Outcomes N/A
Completed NCT01783561 - Early Versus Routine Caffeine Administration in Extremely Preterm Neonates Phase 4
Completed NCT04852315 - Acute Caffeine Ingestion on Futsal Performance N/A
Completed NCT05975489 - Genetics in the Effect of Caffeine on Fat Oxidation N/A
Recruiting NCT03298347 - Caffeine for Preterm Infants With Apnea of Prematurity(AOP) N/A
Completed NCT01435486 - Caffeine Citrate for the Treatment of Apnea Associated With Bronchiolitis in Young Infants N/A
Completed NCT04869176 - Effect of Caffeine on Heart Rate Variability in Newborns N/A
Completed NCT04585854 - Effect of Caffeine on Myocardial Oxygenation N/A